Abstract:During the last few years biosensors have become important for the investigation of biomolecular interactions. In particular surface plasmon resonance (SPR) and resonant mirror (RM) techniques [1] are frequently used in biosensors. More than one thousand publications concerning the use of SPR or RM biosensors underline the importance of these techniques in the analysis of interactions between biomolecules.SPR and RM techniques are optical methods which use evanescent waves [1] to primarily determine the refrac… Show more
“…With a burgeoning demand on environmental monitoring, early disease detection, and food safety, the past decade has witnessed an exponential growth in research and development of bio/chemical sensors. − Among them, label-free optical sensors based on the evanescent field sensing mechanism are powerful analytical techniques for real-time and accurate detection without strict laboratory conditions and extensive sample preparation. , In particular, surface plasmon resonance (SPR)-based sensors are most representative type with ultrahigh sensitivity due to the extremely localized optical field . Currently, the common design of commercial SPR sensors is based on the Kretschmann configuration that incorporates a prism to excite surface plasmon polaritons (SPPs) on the sensing surface.…”
Nanoplasmonic sensors are heralding
exciting advances as clinical
diagnostics as they facilitate label-free, real-time, and ultrasensitive
monitoring in a small footprint. But in essence, almost all of them
still largely rely on expensive and bulky spectroscopy/imaging instrumentation
and methodology, which has become the major impediment for point-of-care
(POC) testing implantation. In this context, an ultracompact optical
sensor is achieved with direct electrical read-out capacity by combining
plasmonic sensing resonance and optical-signal-transducing into a
unity integrated device. Benefiting from the convergence of high figure-of-merit
(∼190) resonance and hot electron enhanced photoelectric conversions
on the near-flat Au-Si nanotrench framework, the device is demonstrated
to yield a detection limit on the order of 10–6 RIU
in a broadband operating wavelength window (700–1700 nm). Such
a compact, silicon process compatible, and ultrasensitive optoelectronic
sensing platform holds great potentials for future clinical POC detection
and on-chip microspectrometer applications.
“…With a burgeoning demand on environmental monitoring, early disease detection, and food safety, the past decade has witnessed an exponential growth in research and development of bio/chemical sensors. − Among them, label-free optical sensors based on the evanescent field sensing mechanism are powerful analytical techniques for real-time and accurate detection without strict laboratory conditions and extensive sample preparation. , In particular, surface plasmon resonance (SPR)-based sensors are most representative type with ultrahigh sensitivity due to the extremely localized optical field . Currently, the common design of commercial SPR sensors is based on the Kretschmann configuration that incorporates a prism to excite surface plasmon polaritons (SPPs) on the sensing surface.…”
Nanoplasmonic sensors are heralding
exciting advances as clinical
diagnostics as they facilitate label-free, real-time, and ultrasensitive
monitoring in a small footprint. But in essence, almost all of them
still largely rely on expensive and bulky spectroscopy/imaging instrumentation
and methodology, which has become the major impediment for point-of-care
(POC) testing implantation. In this context, an ultracompact optical
sensor is achieved with direct electrical read-out capacity by combining
plasmonic sensing resonance and optical-signal-transducing into a
unity integrated device. Benefiting from the convergence of high figure-of-merit
(∼190) resonance and hot electron enhanced photoelectric conversions
on the near-flat Au-Si nanotrench framework, the device is demonstrated
to yield a detection limit on the order of 10–6 RIU
in a broadband operating wavelength window (700–1700 nm). Such
a compact, silicon process compatible, and ultrasensitive optoelectronic
sensing platform holds great potentials for future clinical POC detection
and on-chip microspectrometer applications.
“…2(b) illustrates the ability of the electrode to detect the presence of antibodies in a solution in what is essentially a label free method that requires the user to do no more than expose the sensing interface to the sample of interest. Therefore, protein modulation of electrochemical signals for detecting proteins is a competing technologies to other label-free detection systems such as evanescent wave devices, 15 acoustic wave devices. 16 microcantilevers 17 and nanowire field effect transistors.…”
Herein we present a label-free immunobiosensor based on the modulation of amperometric signals of surface bound redox species when immersed in a protein environment which is applicable to either the detection of antibodies or the detection of small molecules such as drugs or pesticides.
“…Since the development of the first commercial optical biosensor in the late 1980s, the utility of optical biosensors in research and development has been described in over 3,000 scientific publications covering most disciplines found in the pharmaceutical and diagnostic industries. For more detailed information on the application of optical biosensors in the interrogation of intermolecular interactions in general, the reader is referred to recent comprehensive reviews (29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39).…”
Knowledge of the way in which ligands modulate cellular responses via membrane-associated receptors is of central importance to drug discovery and elucidation of signal transduction pathways. Biophysical label-free methods can be used to characterize ligand and drug candidate interactions with neurotransmitters, cytokine receptors, tyrosine kinase receptors, ligand- and voltage-gated ion channels, G protein-coupled receptors (GPCRs), and antibody receptors. Ligand or drug candidate screening typically involves selecting ligands or subsets of a compound library for analysis, transfecting a cell line overexpressing the target receptor, then monitoring one or two downstream reporters of receptor activation such as Ca(2+), cAMP, inositol phosphate, etc. Inevitably, this process leads to a data set predicated by these selections. In contrast, label-free screening techniques allow a holistic, pathway-independent screening strategy to provide a functional or phenotypic readout of receptor activation. Detection techniques that measure changes in cell conductance, viscoelastic properties, refractive index, and other optical parameters that are modulated as a consequence of receptor activation are reviewed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.